Skip to content

Eart 10-501

by Icentia Inc

Eart 10-501 is a Class II device made by Icentia Inc, cleared under FDA 510(k) K223049 on 22 Mar 2023 and listed in FDA GUDID since 26 Mar 2024 (UDI-DI 17540279105018), active as of 12 Nov 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 12 Nov 2026

Documents

510(k) K223049

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 12 Nov 2026.

Regulatory status

as of registry sync 12 Nov 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number17540279105018 UDI-DI Date26 Mar 2024ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK223049 Date22 Mar 2023DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K223049 decided 22 Mar 2023 Active
  • FDA GUDID UDI-DI 17540279105018 listed 26 Mar 2024 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K223049
  2. Listed FDA GUDID 17540279105018

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Eart
Generic name
Electrocardiographic long-term ambulatory recording analyser application software
Model / reference
10-501
Primary DI / UDI-DI
17540279105018
510(k) Number
FDA product code
DSH, DQK
GMDN term
Electrocardiographic long-term ambulatory recording analyser application software
Device class
Class II
Regulation number
870.2800, 870.1425
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Electrocardiographic long-term ambulatory recording analyser application software.

Other devices from Icentia Inc

See all devices from Icentia Inc →

Properties

  • Prescription use
  • Lot / batch number
  • Manufacturing date
Other properties (12, all answered No)